MaxCyte Inc (MXCT) earnings · rev $33.0M
These earnings events as JSON? API free 100/dayMaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
This MXCT earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported MXCT revenue for 2025-12-31 was $33.0M. Net income was -$44.6M. Revenue was down 14.5% from 2024-12-31 to 2025-12-31. MXCT currently screens at market cap $124.3M.
When the next MXCT 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 14.5% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full MXCT research stays on the stock page; the tape stays on the quote page.
MXCT earnings FAQ
What are MXCT's latest revenue and net income?
Latest cached MaxCyte Inc (MXCT) revenue for Dec 31, 2025 was $33.0M. Net income was -$44.6M. Statements: https://lician.com/financials/mxct
What is MXCT's latest diluted EPS?
Latest cached MaxCyte Inc (MXCT) diluted EPS for Dec 31, 2025 was -$0.42.
What period does the latest MXCT earnings print cover?
The latest cached MaxCyte Inc (MXCT) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did MXCT revenue change from the prior cached period?
Cached MaxCyte Inc (MXCT) revenue was down 14.5% from $38.6M (Dec 31, 2024) to $33.0M (Dec 31, 2025). Statements: https://lician.com/financials/mxct
Where are MXCT earnings listed?
Cached earnings facts for MaxCyte Inc (MXCT) are listed at https://lician.com/earnings/mxct. Statements: https://lician.com/financials/mxct
Not investment advice.